Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Yogo, Yurika ^a   Fujishima, Seitaro ^a   Inoue, Takashi ^a   Saito, Fumitake ^a   Shiomi, Takayuki ^a,b   Yamaguchi, Kazuhiro ^a   Ishizaka, Akitoshi ^a  

^a KEIO UNIVERSITY   (Japan)

^b Department of Anatomy   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CCL17 PROTEIN, HUMAN; CCR4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LYMPHOCYTE; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VASCULAR DISEASE; IMMUNOLOGY; IN VITRO STUDY; LUNG; LUNG FIBROSIS; MIDDLE AGED; PATHOLOGY;

ADULT; CHEMOKINE CCL17; CHEMOKINE CCL22; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY FIBROSIS; RECEPTORS, CCR4;

EID: 77955487599     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-80     Document Type: Article

References (26)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002, 165(2):277-304.
2. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001, 345(7):517-525. 10.1056/NEJMra003200, 11519507.
3. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000, 161(2 Pt 1):646-664.
4. Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Ohi M, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005, 171(9):1040-1047. 10.1164/rccm.200404-571OC, 15665326.
5. Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, Yoshie O, Gray PW. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998, 273(3):1764-1768. 10.1074/jbc.273.3.1764, 9430724.
6. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997, 272(23):15036-15042. 10.1074/jbc.272.23.15036, 9169480.
7. Katoh S, Fukushima K, Matsumoto N, Matsumoto K, Abe K, Onai N, Matsushima K, Matsukura S. Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 2003, 58(6):518-523. 10.1034/j.1398-9995.2003.00149.x, 12757454.
8. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002, 38(12-13):881-885. 10.1016/S0161-5890(02)00013-5, 12009564.
9. Belperio JA, Dy M, Murray L, Burdick MD, Xue YY, Strieter RM, Keane MP. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis. J Immunol 2004, 173(7):4692-4698.
10. Pignatti P, Brunetti G, Moretto D, Yacoub MR, Fiori M, Balbi B, Balestrino A, Cervio G, Nava S, Moscato G. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am J Respir Crit Care Med 2006, 173(3):310-317. 10.1164/rccm.200502-244OC, 16239626.
11. Inoue T, Fujishima S, Ikeda E, Yoshie O, Tsukamoto N, Aiso S, Aikawa N, Kubo A, Matsushima K, Yamaguchi K. CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis. Eur Respir J 2004, 24(1):49-56. 10.1183/09031936.04.00110203, 15293604.
12. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986, 133(1):97-103.
13. Nakamura H, Fujishima S, Soejima K, Waki Y, Nakamura M, Ishizaka A, Kanazawa M. Flow cytometric detection of cell-associated cytokines in alveolar macrophages. Eur Respir J 1996, 9(6):1181-1187. 10.1183/09031936.96.09061181, 8804935.
14. Nakamura H, Fujishima S, Waki Y, Urano T, Sayama K, Sakamaki F, Terashima T, Soejima K, Tasaka S, Ishizaka A, et al. Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995, 152(5 Pt 1):1579-1586.
15. Wood GS, Warner NL, Warnke RA. Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. J Immunol 1983, 131(1):212-216.
16. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, Valeyre D, Soumelis V, Crestani B, Soler P. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 2006, 176(10):5735-5739.
17. Penna G, Vulcano M, Sozzani S, Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 2002, 63(12):1164-1171. 10.1016/S0198-8859(02)00755-3, 12480260.
18. Miyazaki E, Nureki S, Fukami T, Shigenaga T, Ando M, Ito K, Ando H, Sugisaki K, Kumamoto T, Tsuda T. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am J Respir Crit Care Med 2002, 165(8):1125-1131.
19. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, Kambouchner M, Valeyre D, Crestani B, Soler P. Dendritic cells accumulate in human fibrotic interstitial lung disease. Am J Respir Crit Care Med 2007, 176(10):1007-1014. 10.1164/rccm.200609-1347OC, 17717200.
20. Sekiya T, Miyamasu M, Imanishi M, Yamada H, Nakajima T, Yamaguchi M, Fujisawa T, Pawankar R, Sano Y, Ohta K, et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000, 165(4):2205-2213.
21. Heijink IH, Marcel Kies P, van Oosterhout AJ, Postma DS, Kauffman HF, Vellenga E. Der p, IL-4, and TGF-beta cooperatively induce EGFR-dependent TARC expression in airway epithelium. Am J Respir Cell Mol Biol 2007, 36(3):351-359. 10.1165/rcmb.2006-0160OC, 17023689.
22. Berin MC, Eckmann L, Broide DH, Kagnoff MF. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 2001, 24(4):382-389.
23. Manabe K, Nishioka Y, Kishi J, Inayama M, Aono Y, Nakamura Y, Ogushi F, Bando H, Tani K, Sone S. Elevation of macrophage-derived chemokine in eosinophilic pneumonia: a role of alveolar macrophages. J Med Invest 2005, 52(1-2):85-92. 10.2152/jmi.52.85, 15751278.
24. Kuroda E, Sugiura T, Okada K, Zeki K, Yamashita U. Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC. J Immunol 2001, 166(3):1650-1658.
25. Fireman E, Ben Efraim S, Greif J, Alguetti A, Ayalon D, Topilsky M. Suppressive activity of alveolar macrophages and blood monocytes from interstitial lung diseases: role of released soluble factors. Int J Immunopharmacol 1989, 11(7):751-760. 10.1016/0192-0561(89)90129-X, 2557288.
26. Trujillo G, O'Connor EC, Kunkel SL, Hogaboam CM. A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis. Am J Pathol 2008, 172(5):1209-1221. 10.2353/ajpath.2008.070832, 2329831, 18403600.